You are here: All Products  > InxMed Completes $19 Million Series A+ Round for FAK Inhibitor Trials

InxMed Completes $19 Million Series A+ Round for FAK Inhibitor Trials

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products